• 2024
  Mistretta M, Cimino M, Campagne P, Volant S, Kornobis E, Hebert O, Rochais C, Dallemagne P, Lecoutey C, Tisnerat C, Lepailleur A, Ayotte Y, LaPlante SR, Gangneux N, Záhorszká M, Korduláková J, Vichier-Guerre S, Bonhomme F, Pokorny L, Albert M, Tinevez JY, Manina G, Dynamic microfluidic single-cell screening identifies pheno-tuning compounds to potentiate tuberculosis therapy., Nat Commun 2024 May; 15(1): 4175.
• 2024
  , Dynamic microfluidic single-cell screening identifies pheno-tuning compounds to potentiate tuberculosis therapy, Nature Communications.
• 2022
  Mistretta M, Gangneux N, Manina G, Microfluidic dose-response platform to track the dynamics of drug response in single mycobacterial cells, Sci Rep 2022 Nov; 12(1): 19578.
• 2016
  Karlas A, Berre S, Couderc T, Varjak M, Braun P, Meyer M, Gangneux N, Karo-Astover L, Weege F, Raftery M, Schönrich G, Klemm U, Wurzlbauer A, Bracher F, Merits A, Meyer TF, Lecuit M, , A human genome-wide loss-of-function screen identifies effective chikungunya antiviral drugs., Nat Commun 2016 May; 7(): 11320.
• 2013
  Judith D, Mostowy S, Bourai M, Gangneux N, Lelek M, Lucas-Hourani M, Cayet N, Jacob Y, Prévost MC, Pierre P, Tangy F, Zimmer C, Vidalain PO, Couderc T, Lecuit M, , Species-specific impact of the autophagy machinery on Chikungunya virus infection., EMBO Rep 2013 Jun; 14(6): 534-44.
• 2012
  Couderc T, Gangneux N, Chrétien F, Caro V, Le Luong T, Ducloux B, Tolou H, Lecuit M, Grandadam M, , Chikungunya virus infection of corneal grafts., J Infect Dis 2012 Sep; 206(6): 851-9.
• 2010
  Schilte C, Couderc T, Chretien F, Sourisseau M, Gangneux N, Guivel-Benhassine F, Kraxner A, Tschopp J, Higgs S, Michault A, Arenzana-Seisdedos F, Colonna M, Peduto L, Schwartz O, Lecuit M, Albert ML, , Type I IFN controls chikungunya virus via its action on nonhematopoietic cells., J Exp Med 2010 Feb; 207(2): 429-42.
• 2009
  Couderc T, Khandoudi N, Grandadam M, Visse C, Gangneux N, Bagot S, Prost JF, Lecuit M, , Prophylaxis and therapy for Chikungunya virus infection., J Infect Dis 2009 Aug; 200(4): 516-23.
• 2008
  Kuo M, Zilberfarb V, Gangneux N, Christeff N, Issad T, , O-GlcNAc modification of FoxO1 increases its transcriptional activity: a role in the glucotoxicity phenomenon?, Biochimie 2008 May; 90(5): 679-85.
• 2008
  Kuo M, Zilberfarb V, Gangneux N, Christeff N, Issad T, , [A new mode of reglulation of FoxO1 by O-GlcNAc glycosylation: involvement in the glucotoxicity phenomenon]., Med Sci (Paris) 2008 Apr; 24(4): 369-71.
• 2008
  Boidot R, Vegran F, Jacob D, Chevrier S, Gangneux N, Taboureau J, Oudin C, Rainville V, Mercier L, Lizard-Nacol S, , The expression of BIRC5 is correlated with loss of specific chromosomal regions in breast carcinomas., Genes Chromosomes Cancer 2008 Apr; 47(4): 299-308.
• 2008
  Kuo M, Zilberfarb V, Gangneux N, Christeff N, Issad T, , O-glycosylation of FoxO1 increases its transcriptional activity towards the glucose 6-phosphatase gene., FEBS Lett 2008 Mar; 582(5): 829-34.